3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Neoplasms
4
Infections
3
Thyroid Nodule
2
Neoplasms, Plasma Cell
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia
2
Febrile Neutropenia
2
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Sepsis
1
Respiratory Sounds
1
Prostatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Emergencies
1
Diverticulitis
1
Cystectomy
1
Brain Neoplasms
1
Astrocytoma
1
Asthma
1
Interventions
Meropenem
5
Ceftazidime
4
Levofloxacin
3
Filgrastim
3
Ciprofloxacin
3
Cefepime
3
Amikacin
3
pegfilgrastim
2
Vancomycin
2
Interleukin 1 Receptor Antagonist Protein
2
Anti-Bacterial Agents
2
Amoxicillin-Potassium Clavulanate Combination
2
pegylated granulocyte colony-stimulating factor
1
Therapeutics
1
Teicoplanin
1
Tazobactam
1
TKN732
1
Surveys and Questionnaires
1
Positron Emission Tomography Computed Tomography
1
Piperacillin
1
Ofloxacin
1
NF protocol
1
Micafungin
1
Metronidazole
1
Magnetic Resonance Myelography
1
Lead
1
Injections
1
Granulocyte Colony-Stimulating Factor
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Febrile Neutropenia
×
Amoxicillin-Potassium Clavulanate Combination
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled
NCT03003273
2019-02-01
DALFEN
All India Institute of Medical Sciences
Phase 3
Terminated
142 enrolled